ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,086.49
0.61%
US Tech 100
20,896.00
1.07%
Dow Jones
45,014.04
0.69%
Brent Oil
72.24
-0.26%
Bitcoin
101,383.36
2.66%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) News

IMAB

I MAB (IMAB)

I MAB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMAB
DateTimeSourceHeadlineSymbolCompany
11/21/20247:00AMPR Newswire (US)I-Mab to Participate at the Piper Sandler Healthcare ConferenceNASDAQ:IMABI MAB
11/14/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
11/14/20247:00AMPR Newswire (US)I-Mab Reports Third Quarter 2024 ResultsNASDAQ:IMABI MAB
11/06/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
11/06/20247:00AMPR Newswire (US)I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive OfficerNASDAQ:IMABI MAB
11/05/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
10/31/20247:00AMPR Newswire (US)I-Mab to Release Q3 2024 Financial Results on November 14, 2024NASDAQ:IMABI MAB
10/30/20247:00AMPR Newswire (US)I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024NASDAQ:IMABI MAB
10/28/20247:00AMPR Newswire (US)I-Mab to Participate at the Truist Securities BioPharma SymposiumNASDAQ:IMABI MAB
10/24/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
09/23/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
09/16/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
09/16/20244:01PMPR Newswire (US)I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024NASDAQ:IMABI MAB
09/10/20247:00AMPR Newswire (US)I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung CancerNASDAQ:IMABI MAB
08/30/20243:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
08/28/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
08/28/20247:00AMPR Newswire (US)I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business UpdatesNASDAQ:IMABI MAB
08/26/20247:00AMPR Newswire (US)I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:IMABI MAB
08/14/20247:00AMPR Newswire (US)I-Mab to Release 1H 2024 Financial Results on August 28, 2024NASDAQ:IMABI MAB
08/07/20247:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
08/07/20247:00AMPR Newswire (US)I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)NASDAQ:IMABI MAB
07/26/20246:20AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
07/17/20246:24AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
07/15/20247:45AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
07/15/20247:30AMPR Newswire (US)I-Mab Announces Leadership TransitionsNASDAQ:IMABI MAB
06/06/20247:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/06/20247:00AMPR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
06/05/20247:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/05/20247:00AMPR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
05/30/20245:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
 Showing the most relevant articles for your search:NASDAQ:IMAB

Your Recent History

USOTC
HMBL
HUMBL (PK)
USOTC
CRTG
Coretec (QB)
COIN
BTCUSD
Bitcoin
USOTC
XERI
Xeriant (QB)
USOTC
NLST
Netlist (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RDGL
Vivos (QB)
USOTC
ZHUD
Zhuding (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
AFFU
Affluence (PK)
AMEX
KULR
KULR Technology
USOTC
MONI
Moon Equity (PK)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
FNMA
Fannie Mae (QB)
USOTC
CGAC
Code Green Apparel (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved